MFGM
NVS icon

Marshall Financial Group (Maryland)’s Novartis NVS Stock Holding History

Marshall Financial Group (Maryland)’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.76M Buy
17,632
+646
+4% +$96.8K 0.4% 51
2026
Q1 		$2.59M Buy
16,986
+127
+0.8% +$19.5K 0.42% 47
2025
Q4 		$2.32M Buy
16,859
+484
+3% +$63.4K 0.45% 47
2025
Q3 		$2.1M Buy
16,375
+741
+5% +$90.4K 0.41% 56
2025
Q2 		$1.91M Buy
+15,634
New +$1.76M 0.37% 55

Other funds holding NVS

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Marshall Financial Group (Maryland)'s NVS Position: Q2 2026 in Review

Marshall Financial Group (Maryland) increased its Novartis (NVS) stake by 3.8% in Q2 2026, buying an estimated $96.8K and bringing the position to 17,632 shares worth $2.76M. The position accounts for 0.4% of the portfolio, ranked #51.

Marshall Financial Group (Maryland) first reported a position in NVS in Q2 2025 and has held it in 5 quarters since. 1,612 funds tracked by Wall St. Rank hold NVS as of Q2 2026.

  • Marshall Financial Group (Maryland) held 17,632 shares of Novartis worth $2.76M as of Q2 2026.
  • Marshall Financial Group (Maryland) bought 646 Novartis shares in Q2 2026, an estimated $96.8K.
  • Novartis made up 0.4% of Marshall Financial Group (Maryland)'s portfolio in Q2 2026, its #51 holding.
  • Marshall Financial Group (Maryland) first reported a position in Novartis in Q2 2025 and has held it in 5 quarters since.
  • 1,612 funds tracked by Wall St. Rank held Novartis as of Q2 2026.

Based on Marshall Financial Group (Maryland)'s 13F filing for Q2 2026, filed 20 Jul 2026.